171 related articles for article (PubMed ID: 36611861)
21. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
[TBL] [Abstract][Full Text] [Related]
22. GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma.
Chen Y; Liu Q; Wu M; Li M; Ding H; Shan X; Liu J; Tao T; Ni R; Chen X
Tumour Biol; 2016 Sep; 37(9):11763-11773. PubMed ID: 27026230
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.
Huang Y; Yang X; Zhao F; Shen Q; Wang Z; Lv X; Hu B; Yu B; Fan J; Qin W
Med Oncol; 2014 Jul; 31(7):966. PubMed ID: 24878698
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
25. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z
Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
28. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Pathol Res Pract; 2019 May; 215(5):939-945. PubMed ID: 30723051
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
Zhou Q; Huang T; Jiang Z; Ge C; Chen X; Zhang L; Zhao F; Zhu M; Chen T; Cui Y; Li H; Yao M; Li J; Tian H
Oncogene; 2020 Mar; 39(10):2140-2155. PubMed ID: 31819169
[TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
33. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
35. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
[TBL] [Abstract][Full Text] [Related]
36. Phosphodiesterases PDE2A and PDE10A both change mRNA expression in the human brain with age, but only PDE2A changes in a region-specific manner with psychiatric disease.
Farmer R; Burbano SD; Patel NS; Sarmiento A; Smith AJ; Kelly MP
Cell Signal; 2020 Jun; 70():109592. PubMed ID: 32119913
[TBL] [Abstract][Full Text] [Related]
37. Modulation of YrdC promotes hepatocellular carcinoma progression via MEK/ERK signaling pathway.
Huang S; Zhu P; Sun B; Guo J; Zhou H; Shu Y; Li Q
Biomed Pharmacother; 2019 Jun; 114():108859. PubMed ID: 30978526
[TBL] [Abstract][Full Text] [Related]
38. DEAD-box Helicase 27 Promotes Hepatocellular Carcinoma Progression Through ERK Signaling.
Xiaoqian W; Bing Z; Yangwei L; Yafei Z; Tingting Z; Yi W; Qingjun L; Suxia L; Ling Z; Bo W; Peng Z
Technol Cancer Res Treat; 2021; 20():15330338211055953. PubMed ID: 34855554
[No Abstract] [Full Text] [Related]
39. Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.
Huang Z; Su G; Bi X; Zhang L; Xu Z; Wang G
Bioengineered; 2021 Dec; 12(1):6952-6966. PubMed ID: 34516353
[TBL] [Abstract][Full Text] [Related]
40. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
